Fact CheckerSign in

NCT06340945Recruiting

The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

The Clinical Outcomes and Artificial Intelligence Prediction Model of Ultrasound-guided Thermal Ablation for the Treatment of Benign Thyroid Nodules:A Multicenter Prospective Study

Source: ClinicalTrials.gov · Last updated 19 Mar 2026

Brief summary (registry, in English)

1. To evaluate the clinical outcomes of ultrasound-guided thermal ablationfor the treatment of benign thyroid nodules; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of benign thyroid nodules

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1500 (estimated)
First submitted
16 Mar 2024
Start date
1 Apr 2024
Primary completion date
31 Dec 2027
Lead sponsor
Chinese PLA General Hospital
NCT number
NCT06340945

What you commit to

  • Study type: Interventional
  • Planned participants: 1500
  • From 1 Apr 2024 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • previous radiation to the head and neck

Other illness

  • follicular neoplasm or malignancy findings on biopsy
  • nodules with benign result on biopsy had suspicious of malignancy in US, including marked hypoechoic, ill-defined margins, taller-than-wide shape or microcalcifications

Other

  • patients with cystic nodules
  • patients with contra-lateral vocal cord par- alysis
  • ; follow- up time less than 6 months

Who the study is looking for

  • \[1\]confirmation of benign nodule status on two separate fine- needle aspiration (FNA) or core-needle biopsy (CNB) \[2\]no suspicious malignant features on ultrasound examination \[3\]report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation \[4\]refusal or ineligibility for surgery \[5\]follow-up time ≥6months

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chinese PLA General Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.